Thomas A Wohl, MD - Medicare Ophthalmology in North Canton, OH

Thomas A Wohl, MD is a medicare enrolled "Ophthalmology" physician in North Canton, Ohio. He went to University Of Cincinnati College Of Medicine and graduated in 1988 and has 36 years of diverse experience with area of expertise as Ophthalmology. He is a member of the group practice Roholt Vision Institute Inc and his current practice location is 5890 Mayfair Rd, North Canton, Ohio. You can reach out to his office (for appointments etc.) via phone at (330) 305-2200.

Thomas A Wohl is licensed to practice in Ohio (license number 35132358) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1538361159.

Contact Information

Thomas A Wohl, MD
5890 Mayfair Rd,
North Canton, OH 44720-1547
(330) 305-2200
(330) 305-2210



Physician's Profile

Full NameThomas A Wohl
GenderMale
SpecialityOphthalmology
Experience36 Years
Location5890 Mayfair Rd, North Canton, Ohio
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Thomas A Wohl attended and graduated from University Of Cincinnati College Of Medicine in 1988
  NPI Data:
  • NPI Number: 1538361159
  • Provider Enumeration Date: 06/05/2007
  • Last Update Date: 07/21/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 4688697840
  • Enrollment ID: I20171013002227

Medical Identifiers

Medical identifiers for Thomas A Wohl such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1538361159NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology 35132358 (Ohio)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Roholt Vision Institute Inc01432043886

News Archive

Missing sequence of the human Y chromosome may contain genes controlling stature and tumor development

Scientists have reported in the journal Genome Research that they have successfully cloned and characterized a previously intractable DNA sequence: a 554-kilobase-pair genomic segment near the centromere of the human Y chromosome. This sequence contains eight putatively active genes that could be implicated in sex-associated height differences and gonadal tumor development.

Marinomed, Boehringer Ingelheim sign licensing agreement for common cold anti-viral nasal spray

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.

Researchers identify new genetic biomarkers that predict outcomes for patients with bowel cancer

Researchers at University of Limerick and University Hospital Limerick have identified several new genetic biomarkers which better predict outcomes for patients with bowel/colorectal cancer. The research team identified genes that are predictors of cancer recurrence and can also help to identify a patients' suitability to specific types of chemotherapy.

Interventions by parent mentors can effectively reduce wheezing and asthma attacks in children

UT Southwestern Medical Center researchers have found that informed adults can help families stave off complications associated with asthma. The findings, available online and in the December issue of Pediatrics, suggest that interventions by parent mentors - caregivers of asthmatic children who have received specialized topical training - can effectively reduce wheezing, asthma attacks, emergency room visits and missed adult workdays.

New MIT drug-delivery nanoparticle could target any type of tumor

MIT chemical engineers have designed a new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumors: They are more acidic than healthy tissues.

Read more Medical News

› Verified 4 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Thomas A Wohl allows following entities to bill medicare on his behalf.
Entity NameRoholt Vision Institute Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1700819455
PECOS PAC ID: 0143204388
Enrollment ID: O20040616000000

News Archive

Missing sequence of the human Y chromosome may contain genes controlling stature and tumor development

Scientists have reported in the journal Genome Research that they have successfully cloned and characterized a previously intractable DNA sequence: a 554-kilobase-pair genomic segment near the centromere of the human Y chromosome. This sequence contains eight putatively active genes that could be implicated in sex-associated height differences and gonadal tumor development.

Marinomed, Boehringer Ingelheim sign licensing agreement for common cold anti-viral nasal spray

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.

Researchers identify new genetic biomarkers that predict outcomes for patients with bowel cancer

Researchers at University of Limerick and University Hospital Limerick have identified several new genetic biomarkers which better predict outcomes for patients with bowel/colorectal cancer. The research team identified genes that are predictors of cancer recurrence and can also help to identify a patients' suitability to specific types of chemotherapy.

Interventions by parent mentors can effectively reduce wheezing and asthma attacks in children

UT Southwestern Medical Center researchers have found that informed adults can help families stave off complications associated with asthma. The findings, available online and in the December issue of Pediatrics, suggest that interventions by parent mentors - caregivers of asthmatic children who have received specialized topical training - can effectively reduce wheezing, asthma attacks, emergency room visits and missed adult workdays.

New MIT drug-delivery nanoparticle could target any type of tumor

MIT chemical engineers have designed a new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumors: They are more acidic than healthy tissues.

Read more Medical News

› Verified 4 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomas A Wohl is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Thomas A Wohl, MD
5890 Mayfair Rd,
North Canton, OH 44720-1547

Ph: (330) 305-2200
Thomas A Wohl, MD
5890 Mayfair Rd,
North Canton, OH 44720-1547

Ph: (330) 305-2200

News Archive

Missing sequence of the human Y chromosome may contain genes controlling stature and tumor development

Scientists have reported in the journal Genome Research that they have successfully cloned and characterized a previously intractable DNA sequence: a 554-kilobase-pair genomic segment near the centromere of the human Y chromosome. This sequence contains eight putatively active genes that could be implicated in sex-associated height differences and gonadal tumor development.

Marinomed, Boehringer Ingelheim sign licensing agreement for common cold anti-viral nasal spray

Marinomed Biotechnologie GmbH, a company focused on the development of innovative therapies for respiratory diseases, announced today that it has signed a licensing agreement with the international pharmaceutical company Boehringer Ingelheim. The deal will aim to further extend marketing of Marinomed's anti-viral nasal spray for the treatment of the Common Cold to all of Europe (except Austria and UK), Russia and CIS, South America, parts of Asia and Australia.

Researchers identify new genetic biomarkers that predict outcomes for patients with bowel cancer

Researchers at University of Limerick and University Hospital Limerick have identified several new genetic biomarkers which better predict outcomes for patients with bowel/colorectal cancer. The research team identified genes that are predictors of cancer recurrence and can also help to identify a patients' suitability to specific types of chemotherapy.

Interventions by parent mentors can effectively reduce wheezing and asthma attacks in children

UT Southwestern Medical Center researchers have found that informed adults can help families stave off complications associated with asthma. The findings, available online and in the December issue of Pediatrics, suggest that interventions by parent mentors - caregivers of asthmatic children who have received specialized topical training - can effectively reduce wheezing, asthma attacks, emergency room visits and missed adult workdays.

New MIT drug-delivery nanoparticle could target any type of tumor

MIT chemical engineers have designed a new type of drug-delivery nanoparticle that exploits a trait shared by almost all tumors: They are more acidic than healthy tissues.

Read more News

› Verified 4 days ago


Ophthalmology Doctors in North Canton, OH

David W Nelson, MD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 6407 Frank Ave Nw, North Canton, OH 44720
Phone: 330-966-1111    Fax: 330-966-8333
Lawrence Ronning, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 6046 Whipple Ave Nw, North Canton, OH 44720
Phone: 330-433-1350    Fax: 330-305-5021
Dr. Pankaj Chand Gupta, M.D.
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 5890 Mayfair Rd, North Canton, OH 44720
Phone: 330-305-2200    Fax: 330-305-2210
Dr. Jason M Young, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 5890 Mayfair Rd, North Canton, OH 44720
Phone: 330-305-2200    
Laurence J Karns, MD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 6407 Frank Ave Nw, North Canton, OH 44720
Phone: 330-966-1111    Fax: 330-966-8333

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.